Filing Flows › Comparisons › OFIX vs NVCR
Orthofix Medical vs NovoCure: OFIX and NVCR compared
Orthofix Medical is the larger company: $211M of revenue in its latest quarter (Q2 FY26) against $193M for NovoCure (Q3 2026). NovoCure is growing faster (+16% against +4% a year earlier). NovoCure is more profitable, with an operating margin of -3.2% against -3.9%.
Where the money goes: OFIX and NVCR
Orthofix Medical (OFIX) · Q2 FY26
Orthofix Medical, Q2 FY26: revenue $211M (+4% year over year), operating margin -3.9%, net loss $15.8M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
NovoCure (NVCR) · Q3 2026
NovoCure, Q3 2026: revenue $193M (+16% year over year), operating margin -3.2%, net loss $10.4M, operating cash flow $22.7M. The chart follows the revenue to costs, profit and cash.
| Orthofix Medical (OFIX) | NovoCure (NVCR) | |
|---|---|---|
| Latest quarter | Q2 FY26 | Q3 2026 |
| Revenue | $211M | $193M |
| Revenue growth, Y/Y | +4% | +16% |
| Operating margin | -3.9% | -3.2% |
| Net earnings | −$15.8M | −$10.4M |
| Net margin | -7.5% | -5.4% |
| Operating cash flow | −$6.2M | $22.7M |
| Free cash flow | — | $15.7M |
Where the revenue comes from
Orthofix Medical
- Global Spine: $173M (82%)
- Global Limb Reconstruction: $37.7M (18%)
Questions
Which is bigger, Orthofix Medical or NovoCure?
Orthofix Medical is the larger company: $211M of revenue in its latest quarter (Q2 FY26) against $193M for NovoCure (Q3 2026).
Is Orthofix Medical or NovoCure growing faster?
NovoCure is growing faster (+16% against +4% a year earlier).
Which is more profitable, Orthofix Medical or NovoCure?
NovoCure is more profitable, with an operating margin of -3.2% against -3.9%.
More: Orthofix Medical earnings · how Orthofix Medical makes money · NovoCure earnings · how NovoCure makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 5, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.